Dried Blood Spot Cards
Because neonatal screening is a vital step in monitoring the health of children, it is essential to have dried blood samples also called Dried Blood Spots (DBS) of good quality to ensure reliable and unequivocal testing results.
903 blotting papers provide a safe and proven method to facilitate sample collection, identification and transport. These newborn screening filter papers are subject to very strict quality controls to ensure uniform composition, thickness, absorption and purity. 903® blotting papers are CE marked and in compliance with the 98/79/EC standard. These dried blood test products are validated according to CLSI LA4-A5 consensus standard requirements and are listed as an FDA Class II medical device.
The standards and controls included in the LaCAR neonatal screening kits are produced with 903® blotting papers.
LaCAR offers standard filter papers and also adapts to the needs of each user by customizing production.
LaCAR offers a variety of pre-printed blotting paper formats designed to meet the majority of needs without specific technical constraints. Standard newborn screening filter papers are ready to use and do not need to be adapted, with a design that suits most circumstances.
- A-AY-026 - DBS 903® card collection
- A-AY-052 - Five ENG form card spots
Standard Dried Blood Spot Testing Papers
Product benefits
ZenTech offers a service to customize filter papers to meet the technical and logistical constraints of each laboratory. Thus, the demographic information, the language, the size of the blotting filter paper, the logo, the number of sampling circles, increasing the serial number, the font color, the bar code, the “OCR-scannable” format, the ideal cassette for automated handling, the carbon copy for duplication of information, the sampling area cover box and others are all options that will adapt your lab filter papers to your needs and reality, in the field.
Unique product code and created by customization
Type Customizable Blotting Filter Papers
Product benefits
Research and Development
Our visionAt LaCAR, we envision a world where everyone benefits from rapid and reliable genetic diagnostics, enabling personalised healthcare while contributing to more equitable and sustainable global public health.
Aware of these challenges, our R&D team is committed to meeting the needs of customers and patients, taking into account the specific recommendations of different countries and continents, as well as advances in academic research and technology.
You have a question regarding our products ? You want to know more about our method ?